TCL Archive “Perhaps the most troubling finding was a broad dissatisfaction with the general ethos within the intramural community.” July 14, 1995
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved February 26, 1993
TCL Archive Finasteride For Prostate Cancer Prevention Causes Little Or No Sexual Dysfunction August 31, 2007
